Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of 4-Methylumbelliferone for Treatment of Chronic Hepatitis B (HBV) and Chronic Hepatitis C (HCV)

NCT00225537 is registered in ClinicalTrials.gov with MTmedical Institute of Health as lead sponsor.

NCT NCT00225537
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00225537 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of 4-Methylumbelliferone for Treatment of Chronic Hepatitis B (HBV) and Chronic Hepatitis C (HCV)
Lead sponsor
MTmedical Institute of Health
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2005
Completion date
August 31, 2007
Enrollment
160
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, chronic hepatitis c